Balchem Stock Forecast, Price & News

-1.92 (-1.46 %)
(As of 06/18/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume184,376 shs
Average Volume123,328 shs
Market Capitalization$4.21 billion
P/E Ratio47.88
Dividend Yield0.44%
30 days | 90 days | 365 days | Advanced Chart
Receive BCPC News and Ratings via Email

Sign-up to receive the latest news and ratings for Balchem and its competitors with MarketBeat's FREE daily newsletter.

Balchem logo

About Balchem

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment also offers microencapsulation solutions; and human grade choline nutrients and mineral amino acid chelated products for wellness applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment offers ethylene oxide primarily for use in the health care industry; and single use canisters with ethylene oxide for sterilizing re-usable devices. This segment also sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. The company sells its products through sales force, independent distributors, and sales agents. Balchem Corporation was incorporated in 1967 and is headquartered in New Hampton, New York.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value





Social Links


Overall MarketRank

1.74 out of 5 stars

Basic Materials Sector

95th out of 891 stocks

Chemicals & Allied Products Industry

10th out of 30 stocks

Analyst Opinion: 1.5Community Rank: 2.6Dividend Strength: 1.7Insider Behavior: 1.7Valuation: 1.3 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Balchem (NASDAQ:BCPC) Frequently Asked Questions

Is Balchem a buy right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Balchem in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Balchem stock.
View analyst ratings for Balchem
or view top-rated stocks.

What stocks does MarketBeat like better than Balchem?

Wall Street analysts have given Balchem a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Balchem wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Balchem's next earnings date?

Balchem is scheduled to release its next quarterly earnings announcement on Friday, July 30th 2021.
View our earnings forecast for Balchem

How were Balchem's earnings last quarter?

Balchem Co. (NASDAQ:BCPC) announced its quarterly earnings results on Thursday, April, 29th. The basic materials company reported $0.87 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $0.80 by $0.07. The basic materials company had revenue of $185.70 million for the quarter, compared to the consensus estimate of $181.59 million. Balchem had a net margin of 12.35% and a trailing twelve-month return on equity of 13.35%. The firm's quarterly revenue was up 6.4% on a year-over-year basis. During the same period last year, the firm posted $0.81 EPS.
View Balchem's earnings history

How has Balchem's stock price been impacted by COVID-19 (Coronavirus)?

Balchem's stock was trading at $89.29 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, BCPC stock has increased by 45.3% and is now trading at $129.76.
View which stocks have been most impacted by COVID-19

How often does Balchem pay dividends? What is the dividend yield for Balchem?

Balchem announced an annual dividend on Thursday, December 17th. Stockholders of record on Monday, December 28th will be paid a dividend of $0.58 per share on Friday, January 22nd. This represents a yield of 0.5%. The ex-dividend date is Thursday, December 24th. This is an increase from Balchem's previous annual dividend of $0.26.
View Balchem's dividend history

Is Balchem a good dividend stock?

Balchem pays an annual dividend of $0.58 per share and currently has a dividend yield of 0.44%. Balchem does not yet have a strong track record of dividend growth. The dividend payout ratio of Balchem is 17.47%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Balchem will have a dividend payout ratio of 15.55% next year. This indicates that Balchem will be able to sustain or increase its dividend.
View Balchem's dividend history.

What price target have analysts set for BCPC?

2 analysts have issued 12-month price objectives for Balchem's shares. Their forecasts range from $140.00 to $145.00. On average, they anticipate Balchem's share price to reach $142.50 in the next year. This suggests a possible upside of 9.8% from the stock's current price.
View analysts' price targets for Balchem
or view top-rated stocks among Wall Street analysts.

Who are Balchem's key executives?

Balchem's management team includes the following people:
  • Mr. Theodore L. Harris, Chairman, CEO & Pres (Age 56, Pay $2.37M)
  • Mr. Carl Martin Bengtsson, CFO & Treasurer
  • Mr. Mark A. Stach, Gen. Counsel & Corp. Sec.
  • Mr. James C. Hyde, Sr. VP and GM of Human Nutrition & Health

What is Dino A. Rossi's approval rating as Balchem's CEO?

15 employees have rated Balchem CEO Dino A. Rossi on Dino A. Rossi has an approval rating of 85% among Balchem's employees.

Who are some of Balchem's key competitors?

What other stocks do shareholders of Balchem own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Balchem investors own include Ecolab (ECL), CVS Health (CVS), AbbVie (ABBV), Johnson & Johnson (JNJ), Lowe's Companies (LOW), Altria Group (MO), NVIDIA (NVDA), AT&T (T), Analog Devices (ADI) and Bristol-Myers Squibb (BMY).

What is Balchem's stock symbol?

Balchem trades on the NASDAQ under the ticker symbol "BCPC."

Who are Balchem's major shareholders?

Balchem's stock is owned by a number of retail and institutional investors. Top institutional investors include BlackRock Inc. (15.96%), Wasatch Advisors Inc. (4.72%), Brown Capital Management LLC (3.61%), Conestoga Capital Advisors LLC (2.94%), Dimensional Fund Advisors LP (2.16%) and Schroder Investment Management Group (2.14%). Company insiders that own Balchem stock include David F Ludwig and Scott C Mason.
View institutional ownership trends for Balchem

Which institutional investors are selling Balchem stock?

BCPC stock was sold by a variety of institutional investors in the last quarter, including Brown Capital Management LLC, Renaissance Technologies LLC, Royce & Associates LP, Schroder Investment Management Group, Goldman Sachs Group Inc., Tributary Capital Management LLC, Citadel Advisors LLC, and Healthcare of Ontario Pension Plan Trust Fund.
View insider buying and selling activity for Balchem
or view top insider-selling stocks.

Which institutional investors are buying Balchem stock?

BCPC stock was acquired by a variety of institutional investors in the last quarter, including APG Asset Management N.V., Wasatch Advisors Inc., BlackRock Inc., Lord Abbett & CO. LLC, Assenagon Asset Management S.A., Fred Alger Management LLC, Davy Global Fund Management Ltd, and Ameriprise Financial Inc..
View insider buying and selling activity for Balchem
or or view top insider-buying stocks.

How do I buy shares of Balchem?

Shares of BCPC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Balchem's stock price today?

One share of BCPC stock can currently be purchased for approximately $129.76.

How much money does Balchem make?

Balchem has a market capitalization of $4.21 billion and generates $703.64 million in revenue each year. The basic materials company earns $84.62 million in net income (profit) each year or $3.32 on an earnings per share basis.

How many employees does Balchem have?

Balchem employs 1,342 workers across the globe.

When was Balchem founded?

Balchem was founded in 1967.

What is Balchem's official website?

The official website for Balchem is

Where are Balchem's headquarters?

Balchem is headquartered at 52 Sunrise Park Road, NEW HAMPTON NY, 10958.

How can I contact Balchem?

Balchem's mailing address is 52 Sunrise Park Road, NEW HAMPTON NY, 10958. The basic materials company can be reached via phone at 845-326-5600 or via email at [email protected]

This page was last updated on 6/20/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.